Biosolution Co., Ltd.
- Biotech or pharma, therapeutic R&D
Biosolution Co., Ltd. (KOSDAQ-listed) is a clinical-stage biotech company based in South Korea, specializing in cell therapies for degenerative diseases and wound healing. Its lead products include CartiLife®, an autologous cartilage cell therapy approved in Korea for osteoarthritis, and KeraHeal-Allo®, an allogeneic keratinocyte-based therapy approved for wound healing, with potential label expansion to ulcers, diabetic ulcers, and bedsores. Biosolution is actively seeking global partners for co-development, licensing, and commercialization.
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}